• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三磷酸鸟苷(GTP)池耗竭不是利巴韦林对拉沙病毒发挥抗病毒作用的主要机制。

Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.

机构信息

Department of Virology, Bernhard-Nocht-Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359 Hamburg, Germany.

出版信息

Antiviral Res. 2011 Aug;91(2):89-93. doi: 10.1016/j.antiviral.2011.05.006. Epub 2011 May 17.

DOI:10.1016/j.antiviral.2011.05.006
PMID:21616094
Abstract

Ribavirin (1-β-d-ribofuranosyl-1,2,4-triazole-3-carboxamide) is the standard treatment for Lassa fever, though its mode of action is unknown. One possibility is depletion of the intracellular GTP pool via inhibition of the cellular enzyme inosine monophosphate dehydrogenase (IMPDH). This study compared the anti-arenaviral effect of ribavirin with that of two other IMPDH inhibitors, mycophenolic acid (MPA) and 5-ethynyl-1-β-d-ribofuranosylimidazole-4-carboxamide (EICAR). All three compounds were able to inhibit Lassa virus replication by ≥2 log units in cell culture. Restoring the intracellular GTP pool by exogenous addition of guanosine reversed the inhibitory effects of MPA and EICAR, while ribavirin remained fully active. Analogous experiments performed with Zaire Ebola virus showed that IMPDH inhibitors are also active against this virus, although to a lesser extent than against Lassa virus. In conclusion, the experiments with MPA and EICAR indicate that replication of Lassa and Ebola virus is sensitive to depletion of the GTP pool mediated via inhibition of IMPDH. However, this is not the predominant mechanism by which ribavirin exerts its in-vitro antiviral effect on Lassa virus.

摘要

利巴韦林(1-β-d- 呋喃核糖基-1,2,4-三唑-3-羧酰胺)是治疗拉沙热的标准药物,但其作用机制尚不清楚。一种可能性是通过抑制细胞内酶肌苷单磷酸脱氢酶(IMPDH)来耗尽细胞内 GTP 池。本研究比较了利巴韦林与另外两种 IMPDH 抑制剂霉酚酸(MPA)和 5-乙炔基-1-β-d-呋喃核糖基咪唑-4-羧酰胺(EICAR)的抗沙波病毒作用。这三种化合物在细胞培养中均能抑制拉沙病毒复制≥2 个对数单位。通过外源性添加鸟苷恢复细胞内 GTP 池,可逆转 MPA 和 EICAR 的抑制作用,而利巴韦林仍保持完全活性。用扎伊尔埃博拉病毒进行的类似实验表明,IMPDH 抑制剂对该病毒也具有活性,尽管其活性低于拉沙病毒。总之,与 MPA 和 EICAR 的实验表明,拉沙病毒和埃博拉病毒的复制对通过抑制 IMPDH 导致的 GTP 池耗竭敏感。然而,这不是利巴韦林在体外对拉沙病毒发挥抗病毒作用的主要机制。

相似文献

1
Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.三磷酸鸟苷(GTP)池耗竭不是利巴韦林对拉沙病毒发挥抗病毒作用的主要机制。
Antiviral Res. 2011 Aug;91(2):89-93. doi: 10.1016/j.antiviral.2011.05.006. Epub 2011 May 17.
2
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.利巴韦林在体外对黄病毒和副粘病毒发挥抗病毒活性的主要机制是通过抑制肌苷酸脱氢酶介导的。
J Virol. 2005 Feb;79(3):1943-7. doi: 10.1128/JVI.79.3.1943-1947.2005.
3
The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.利巴韦林的抗黄热病毒活性与易出错复制无关。
Mol Pharmacol. 2006 Apr;69(4):1461-7. doi: 10.1124/mol.105.020057. Epub 2006 Jan 18.
4
Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells.细胞 IMPDH 酶活性是抑制基孔肯雅热病毒复制和病毒诱导的培养哺乳动物细胞凋亡的潜在靶点。
Antiviral Res. 2011 Jan;89(1):1-8. doi: 10.1016/j.antiviral.2010.10.009. Epub 2010 Nov 9.
5
Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.利巴韦林对汉坦病毒的活性与利巴韦林-5'-三磷酸的产生相关,而与肌苷酸脱氢酶的抑制无关。
Antimicrob Agents Chemother. 2007 Jan;51(1):84-8. doi: 10.1128/AAC.00790-06. Epub 2006 Oct 23.
6
Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.EICAR 对犬瘟热病毒(CDV)的体外抗病毒功效。
Res Vet Sci. 2010 Apr;88(2):339-44. doi: 10.1016/j.rvsc.2009.08.010. Epub 2009 Sep 24.
7
Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro.利巴韦林和霉酚酸对正痘病毒的体外抗病毒活性及作用方式研究
Antivir Chem Chemother. 2001 Nov;12(6):327-35. doi: 10.1177/095632020101200602.
8
In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.体外实验中,氨多索韦与肌苷单磷酸脱氢酶抑制剂霉酚酸和利巴韦林联合使用,对1型人类免疫缺陷病毒的野生型和耐药变异株均显示出强大的活性。
Antimicrob Agents Chemother. 2004 Nov;48(11):4387-94. doi: 10.1128/AAC.48.11.4387-4394.2004.
9
1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.1-β-D-呋喃核糖基-1,2,4-三唑-3-甲酰胺(利巴韦林)和5-乙炔基-1-β-D-呋喃核糖基咪唑-4-甲酰胺(EICAR)显著增强2',3'-双脱氧肌苷对外周血淋巴细胞中人类免疫缺陷病毒的抑制作用。
Biochem Biophys Res Commun. 1991 Jul 31;178(2):563-9. doi: 10.1016/0006-291x(91)90145-w.
10
Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.肌苷-5'-单磷酸脱氢酶(IMPDH)抑制剂作为潜在的抗牛病毒性腹泻病毒药物
Antivir Chem Chemother. 2002 Nov;13(6):345-52. doi: 10.1177/095632020201300602.

引用本文的文献

1
Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology.普马拉正汉坦病毒:流行情况、生物学特性、疾病、动物模型以及治疗学开发与结构生物学的最新进展
Front Immunol. 2025 May 8;16:1575112. doi: 10.3389/fimmu.2025.1575112. eCollection 2025.
2
Treatment of highly virulent mammarenavirus infections-status quo and future directions.高毒力哺乳动物沙粒病毒感染的治疗-现状和未来方向。
Expert Opin Drug Discov. 2024 May;19(5):537-551. doi: 10.1080/17460441.2024.2340494. Epub 2024 Apr 12.
3
Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents.
鉴定 IMP 脱氢酶为抗猴痘病毒药物的潜在靶标。
Microbiol Spectr. 2023 Aug 17;11(4):e0056623. doi: 10.1128/spectrum.00566-23. Epub 2023 Jul 6.
4
Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy.作为广谱抗病毒化疗候选药物的核苷酸生物合成抑制剂
Microorganisms. 2022 Aug 12;10(8):1631. doi: 10.3390/microorganisms10081631.
5
Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system.抗病毒药物在 COVID-19 中的再利用及其对神经系统的影响。
Microb Pathog. 2022 Jul;168:105608. doi: 10.1016/j.micpath.2022.105608. Epub 2022 May 30.
6
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.利巴韦林治疗拉沙热:临床前研究的系统评价及其对人体剂量的影响。
PLoS Negl Trop Dis. 2022 Mar 30;16(3):e0010289. doi: 10.1371/journal.pntd.0010289. eCollection 2022 Mar.
7
The Multiple Regulatory Relationship Between RNA-Chaperone Hfq and the Second Messenger c-di-GMP.RNA伴侣蛋白Hfq与第二信使环二鸟苷酸之间的多重调控关系
Front Microbiol. 2021 Jul 14;12:689619. doi: 10.3389/fmicb.2021.689619. eCollection 2021.
8
Management of Lassa Fever: A Current Update.拉沙热的管理:最新进展
Cureus. 2021 May 2;13(5):e14797. doi: 10.7759/cureus.14797.
9
Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections.将病毒基因组合成作为对抗RNA病毒感染的广谱方法。
Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620976786. doi: 10.1177/2040206620976786.
10
Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.药物重定位方法对抗冠状病毒:潜在药物和药物靶点。
Med Res Rev. 2021 May;41(3):1375-1426. doi: 10.1002/med.21763. Epub 2020 Dec 5.